Freshfields LLP

We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Freshfields boasts a robust transactional practice, advising clients on high-value domestic and international M&A deals and license and collaboration agreements. New York-based Adam Golden leads the practice, advising emerging and established life sciences companies on M&A, licensing and collaborations, venture capital financings, and commercial transactions. Vinita Kailasanath, based in Silicon Valley, is experienced in strategic intellectual property and transactions at the convergence of life sciences and tech. The team saw significant expansion in 2024, with the arrivals of private capital-focused Eva Mak in Silicon Valley, and M&A expert Steven Li in New York from Kirkland & Ellis. On the private equity side, Neal Reenan and Ian Bushner joined the New York office, while capital markets expert Phillip Stroup arrived in Silicon Valley – all from Latham & Watkins LLP.
Legal 500 Editorial commentary

Key clients

  • Johnson & Johnson
  • AstraZeneca

Work highlights

Advised Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.